Pioneering mRNA technology - Moderna
Learn how we’re changing the world of medicine. Discover career opportunities, our product pipeline, and browse media resources. Meet Moderna.
Moderna Files for FDA Authorization of Its Updated COVID-19 …
Jun 22, 2023 · To learn more, visit www.modernatx.com. AUTHORIZED USE IN THE U.S. Emergency uses of the vaccine have not been approved or licensed by the FDA, but have …
Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine
Sep 11, 2023 · To learn more, visit www.modernatx.com. AUTHORIZED USE IN THE U.S. Emergency uses of the Moderna COVID-19 Vaccine (2023-2024 Formula) have not been …
mRNA medicines we are currently developing - Moderna
Track the development of Moderna’s mRNA medicines. From preclinical development to commercial phase.
Our Story - Moderna
We’re making biotech history. Since 2010, we have worked to build the industry's leading mRNA technology platform. Learn more about Moderna’s history.
Moderna COVID-19 Vaccine (2024-2025 Formula) | Moderna
In addition, you can report side effects to ModernaTX, Inc. at 1-866-MODERNA (1-866-663-3762). Please see the Moderna COVID-19 Vaccine (2024-2025 Formula) Fact Sheet for Recipients …
Moderna Achieves Positive Interim Results from Phase 3 Trial of …
Mar 26, 2024 · For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn. Spikevax ® is a …
Moderna Advances Multiple Vaccine Programs to Late-Stage …
Mar 27, 2024 · For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn. INDICATION …
Investor Relations Overview - Moderna
[email protected]. Investor Email Alerts. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your …
Moderna Expands the Field of mRNA Medicine with Positive …
Sep 13, 2023 · To learn more, visit www.modernatx.com. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities …